Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Start 7-day free trial → Log in

Lactulose · Chronulac, NSC-757082

Other · developed by Sanofi Aventis Us

Approved FDA, Jun 1979

2 Registered trials

What is Lactulose?

Lactulose is a synthetic disaccharide used as a bowel preparation agent. It was studied in combination with bisacodyl at various doses for colonoscopy preparation.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as: Chronulac, NSC-757082
Drug type: Other
Therapy area: Gastroenterology
Developer: Sanofi Aventis Us
In trials of: CPIX
FDA status: Approved as Chronulac (June 20, 1979), NDA017884
UNII: 9U7D5QH5AE

🧪 Clinical trials

Trial	Phase	Condition	Status	Sponsor
NCT02123017	Phase 2	Colonoscopy Preparation	Completed	CPIX
NCT01650870	Phase 2	Colonoscopy	Completed	CPIX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

ColonoscopyColonoscopy Preparation

Sources

Updated Oct 3, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z